FdaApplication

ANDA 219539

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMSN LABORATORIES PRIVATE LTD
application_typeANDA
approval_date2025-11-04

Products (3)

ProductActive ingredientStrengthDosage form
IRBESARTANIRBESARTAN150MGTABLET;ORAL
IRBESARTANIRBESARTAN300MGTABLET;ORAL
IRBESARTANIRBESARTAN75MGTABLET;ORAL

3 products